These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 17266770)
21. Expression of factors associated with apoptosis in the porcine corpus luteum throughout the luteal phase of the estrous cycle and early pregnancy: their possible involvement in acquisition of luteolytic sensitivity. Przygrodzka E; Witek KJ; Kaczmarek MM; Andronowska A; Ziecik AJ Theriogenology; 2015 Mar; 83(4):535-45. PubMed ID: 25457680 [TBL] [Abstract][Full Text] [Related]
22. CD40, CD80, and CD86 costimulatory molecules are differentially expressed on murine splenic antigen-presenting cells during the pre-implantation period of pregnancy, and they modulate regulatory T-cell abundance, peripheral cytokine response, and pregnancy outcome. Slawek A; Maj T; Chelmonska-Soyta A Am J Reprod Immunol; 2013 Aug; 70(2):116-26. PubMed ID: 23445188 [TBL] [Abstract][Full Text] [Related]
23. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1. Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458 [TBL] [Abstract][Full Text] [Related]
24. Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma. Chang CS; Chang JH; Hsu NC; Lin HY; Chung CY BMC Cancer; 2007 May; 7():88. PubMed ID: 17524139 [TBL] [Abstract][Full Text] [Related]
26. Cross-species costimulation: relative contributions of CD80, CD86, and CD40. Rogers NJ; Jackson IM; Jordan WJ; Hawadle MA; Dorling A; Lechler RI Transplantation; 2003 Jun; 75(12):2068-76. PubMed ID: 12829914 [TBL] [Abstract][Full Text] [Related]
27. Clinical significance of costimulatory molecules CD80/CD86 expression in IgA nephropathy. Wu Q; Jinde K; Endoh M; Sakai H Kidney Int; 2004 Mar; 65(3):888-96. PubMed ID: 14871408 [TBL] [Abstract][Full Text] [Related]
28. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Nestle FO; Burg G; Fäh J; Wrone-Smith T; Nickoloff BJ Am J Pathol; 1997 Feb; 150(2):641-51. PubMed ID: 9033277 [TBL] [Abstract][Full Text] [Related]
29. Participation of specific PKC isozymes in the inhibitory effect of ET-1 on progesterone accumulation in cells isolated from early- and mid-phase corpora lutea. Sen A; Wright M; Inskeep EK; Flores JA Domest Anim Endocrinol; 2006 Oct; 31(3):284-99. PubMed ID: 16388928 [TBL] [Abstract][Full Text] [Related]
30. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II. Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390 [TBL] [Abstract][Full Text] [Related]
31. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity. Smythe JA; Fink PD; Logan GJ; Lees J; Rowe PB; Alexander IE J Immunol; 1999 Sep; 163(6):3239-49. PubMed ID: 10477593 [TBL] [Abstract][Full Text] [Related]
32. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117 [TBL] [Abstract][Full Text] [Related]
33. Costimulatory molecules CD80 and CD86 in the rat; tissue distribution and expression by antigen-presenting cells. Damoiseaux JG; Yagita H; Okumura K; van Breda Vriesman PJ J Leukoc Biol; 1998 Dec; 64(6):803-9. PubMed ID: 9850164 [TBL] [Abstract][Full Text] [Related]
34. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin. Mukherjee S; Maiti PK; Nandi D J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713 [TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor-alpha and its receptor in bovine corpus luteum throughout the estrous cycle. Sakumoto R; Berisha B; Kawate N; Schams D; Okuda K Biol Reprod; 2000 Jan; 62(1):192-9. PubMed ID: 10611085 [TBL] [Abstract][Full Text] [Related]
36. The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation. Inobe M; Aoki N; Linsley PS; Ledbetter JA; Abe R; Murakami M; Uede T J Immunol; 1996 Jul; 157(2):582-8. PubMed ID: 8752905 [TBL] [Abstract][Full Text] [Related]
37. Effects of prostaglandin F2alpha and progesterone on the ability of bovine luteal cells to stimulate T lymphocyte proliferation. Cannon MJ; Petroff MG; Pate JL Biol Reprod; 2003 Aug; 69(2):695-700. PubMed ID: 12724272 [TBL] [Abstract][Full Text] [Related]
38. Possible role of interleukin-1 in the regulation of bovine corpus luteum throughout the luteal phase. Nishimura R; Bowolaksono A; Acosta TJ; Murakami S; Piotrowska K; Skarzynski DJ; Okuda K Biol Reprod; 2004 Nov; 71(5):1688-93. PubMed ID: 15253926 [TBL] [Abstract][Full Text] [Related]
39. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824 [TBL] [Abstract][Full Text] [Related]
40. Is corpus luteum regression an immune-mediated event? Localization of immune system components and luteinizing hormone receptor in human corpora lutea. Bukovský A; Caudle MR; Keenan JA; Wimalasena J; Upadhyaya NB; Van Meter SE Biol Reprod; 1995 Dec; 53(6):1373-84. PubMed ID: 8562694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]